SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Shyamal H. Mehta, Charles H. Adler, Advances in Biomarker Research in Parkinson’s Disease, Current Neurology and Neuroscience Reports, 2016, 16, 1

    CrossRef

  2. 2
    Matteo Bologna, Antonio Suppa, Antonella Conte, Anna Latorre, John C. Rothwell, Alfredo Berardelli, Are studies of motor cortex plasticity relevant in human patients with Parkinson’s disease?, Clinical Neurophysiology, 2016, 127, 1, 50

    CrossRef

  3. 3
    Andrius Sakalauskas, Kristina Laučkaitė, Arūnas Lukoševičius, Daiva Rastenytė, Computer-Aided Segmentation of the Mid-Brain in Trans-Cranial Ultrasound Images, Ultrasound in Medicine & Biology, 2016, 42, 1, 322

    CrossRef

  4. 4
    Ane Løvli Stav, Krisztina Kunszt Johansen, Eirik Auning, Lisa Flem Kalheim, Per Selnes, Atle Bjørnerud, Erik Hessen, Dag Aarsland, Tormod Fladby, Hippocampal subfield atrophy in relation to cerebrospinal fluid biomarkers and cognition in early Parkinson’s disease: a cross-sectional study, npj Parkinson's Disease, 2016, 2, 15030

    CrossRef

  5. 5
    Michele Ragno, Sandro Sanguigni, Antonio Manca, Luigi Pianese, Cristina Paci, Alfonso Berbellini, Valeria Cozzolino, Roberto Gobbato, Silvio Peluso, Giuseppe De Michele, Parkinsonism in a pair of monozygotic CADASIL twins sharing the R1006C mutation: a transcranial sonography study, Neurological Sciences, 2016,

    CrossRef

  6. 6
    Gang Wu, Yi-Jian Shen, Mei-Hua Huang, Zhen Xing, Ying Liu, Jin Chen, Proton MR Spectroscopy for Monitoring Pathologic Changes in the Substantia Nigra and Globus Pallidus in Parkinson Disease, American Journal of Roentgenology, 2016, 206, 2, 385

    CrossRef

  7. 7
    Rohan R. Mahale, Ravi Yadav, Pramod Kr. Pal, Rapid eye movement sleep behaviour disorder in women with Parkinson’s disease is an underdiagnosed entity, Journal of Clinical Neuroscience, 2016,

    CrossRef

  8. 8
    Francesco Brigo, Giulia Turri, Michele Tinazzi, 123I-FP-CIT SPECT in the differential diagnosis between dementia with Lewy bodies and other dementias, Journal of the Neurological Sciences, 2015, 359, 1-2, 161

    CrossRef

  9. 9
    Ane Løvli Stav, Dag Aarsland, Krisztina Kunszt Johansen, Erik Hessen, Eirik Auning, Tormod Fladby, Amyloid-β and α-synuclein cerebrospinal fluid biomarkers and cognition in early Parkinson's disease, Parkinsonism & Related Disorders, 2015, 21, 7, 758

    CrossRef

  10. 10
    M. B. Aerts, R. A. J. Esselink, W. F. Abdo, F. J. A. Meijer, G. Drost, N. Norgren, M. J. R. Janssen, G. F. Borm, B. R. Bloem, M. M. Verbeek, Ancillary investigations to diagnose parkinsonism: a prospective clinical study, Journal of Neurology, 2015, 262, 2, 346

    CrossRef

  11. 11
    G. Salazar, J. Martín, M. Fragoso, M.A. Font, Apomorfina en bomba de perfusión continua en pacientes con enfermedad de Parkinson avanzada con diferente grado de afectación funcional, Neurología, 2015,

    CrossRef

  12. 12
    Davide V. Moretti, Are there treatments for atypical parkinsonism? An update on actual options, Reviews in the Neurosciences, 2015, 26, 5

    CrossRef

  13. 13
    Camilla Rocchi, Mariangela Pierantozzi, Salvatore Galati, Agostino Chiaravalloti, Valerio Pisani, Chiara Prosperetti, Benedetta Lauretti, Mario Stampanoni Bassi, Enrica Olivola, Orazio Schillaci, Alessandro Stefani, Autonomic Function Tests and MIBG in Parkinson's Disease: Correlation to Disease Duration and Motor Symptoms, CNS Neuroscience & Therapeutics, 2015, 21, 9
  14. 14
    Isabella Berardelli, Massimo Pasquini, Maria Bloise, Lorenzo Tarsitani, Massimo Biondi, Alfredo Berardelli, Giovanni Fabbrini, CBT Group Intervention for Depression, Anxiety, and Motor Symptoms in Parkinson's Disease: Preliminary Findings, International Journal of Cognitive Therapy, 2015, 8, 1, 11

    CrossRef

  15. 15
    Marco Barbariga, Flavio Curnis, Annapaola Andolfo, Alan Zanardi, Massimo Lazzaro, Antonio Conti, Giuseppe Magnani, Maria Antonietta Volontè, Laura Ferrari, Giancarlo Comi, Angelo Corti, Massimo Alessio, Ceruloplasmin functional changes in Parkinson’s disease-cerebrospinal fluid, Molecular Neurodegeneration, 2015, 10, 1

    CrossRef

  16. 16
    M. Cosottini, D. Frosini, I. Pesaresi, G. Donatelli, P. Cecchi, M. Costagli, L. Biagi, R. Ceravolo, U. Bonuccelli, M. Tosetti, Comparison of 3T and 7T Susceptibility-Weighted Angiography of the Substantia Nigra in Diagnosing Parkinson Disease, American Journal of Neuroradiology, 2015, 36, 3, 461

    CrossRef

  17. 17
    Andrea Pilotto, Rezzak Yilmaz, Daniela Berg, Developments in the Role of Transcranial Sonography for the Differential Diagnosis of Parkinsonism, Current Neurology and Neuroscience Reports, 2015, 15, 7

    CrossRef

  18. 18
    F. Di Biasio, A. Conte, M. Bologna, E. Iezzi, L. Rocchi, N. Modugno, A. Berardelli, Does the cerebellum intervene in the abnormal somatosensory temporal discrimination in Parkinson's disease?, Parkinsonism & Related Disorders, 2015, 21, 7, 789

    CrossRef

  19. 19
    Matteo Bologna, Francesca Di Biasio, Antonella Conte, Ennio Iezzi, Nicola Modugno, Alfredo Berardelli, Effects of cerebellar continuous theta burst stimulation on resting tremor in Parkinson's disease, Parkinsonism & Related Disorders, 2015, 21, 9, 1061

    CrossRef

  20. 20
    Filip Scheperjans, Velma Aho, Pedro A. B. Pereira, Kaisa Koskinen, Lars Paulin, Eero Pekkonen, Elena Haapaniemi, Seppo Kaakkola, Johanna Eerola-Rautio, Marjatta Pohja, Esko Kinnunen, Kari Murros, Petri Auvinen, Gut microbiota are related to Parkinson's disease and clinical phenotype, Movement Disorders, 2015, 30, 3
  21. 21
    Clelia Pellicano, Francesca Assogna, Luca Cravello, Roberto Langella, Carlo Caltagirone, Gianfranco Spalletta, Francesco E. Pontieri, Neuropsychiatric and cognitive symptoms and body side of onset of parkinsonism in unmedicated Parkinson's disease patients, Parkinsonism & Related Disorders, 2015, 21, 9, 1096

    CrossRef

  22. 22
    Marcello Moccia, Brit Mollenhauer, Roberto Erro, Marina Picillo, Raffaele Palladino, Paolo Barone, Non-Motor Correlates of Smoking Habits in de Novo Parkinson’s Disease, Journal of Parkinson's Disease, 2015, 5, 4, 913

    CrossRef

  23. 23
    Yin Xia Chao, Lai Mun Chew, Xiao Deng, Eng-King Tan, Nonmotor symptoms in sporadic versus familial forms of Parkinson's disease, Neurodegenerative Disease Management, 2015, 5, 2, 147

    CrossRef

  24. 24
    Malco Rossi, Santiago Perez-Lloret, Patricio Millar Vernetti, Lucas Drucaroff, Elsa Costanzo, Diego Ballesteros, Andrea Bril, Daniel Cerquetti, Salvador Guinjoan, Marcelo Merello, Olfactory Dysfunction Evaluation Is Not Affected by Comorbid Depression in Parkinson's Disease, Movement Disorders, 2015, 30, 9
  25. 25
    Jung Han Yoon, Min Kim, So Young Moon, Seok Woo Yong, Ji Man Hong, Olfactory function and neuropsychological profile to differentiate dementia with Lewy bodies from Alzheimer's disease in patients with mild cognitive impairment: A 5-year follow-up study, Journal of the Neurological Sciences, 2015, 355, 1-2, 174

    CrossRef

  26. 26
    Diane Stephenson, Michele T. Hu, Klaus Romero, Kieran Breen, David Burn, Yoav Ben-Shlomo, Atul Bhattaram, Maria Isaac, Charles Venuto, Ken Kubota, Max A. Little, Stephen Friend, Simon Lovestone, Huw R. Morris, Donald Grosset, Margaret Sutherland, John Gallacher, Caroline Williams-Gray, Lisa J. Bain, Enrique Avilés, Ken Marek, Arthur W. Toga, Yafit Stark, Mark Forrest Gordon, Steve Ford, Precompetitive Data Sharing as a Catalyst to Address Unmet Needs in Parkinson’s Disease 1, Journal of Parkinson's Disease, 2015, 5, 3, 581

    CrossRef

  27. 27
    Rohan Mahale, Ravi Yadav, Pramod Kr. Pal, Quality of sleep in young onset Parkinson's disease: Any difference from older onset Parkinson's disease, Parkinsonism & Related Disorders, 2015, 21, 5, 461

    CrossRef

  28. 28
    Marcello Moccia, Roberto Erro, Marina Picillo, Edoardo Vassallo, Carmine Vitale, Katia Longo, Marianna Amboni, Gabriella Santangelo, Raffaele Palladino, Antonio Nardone, Maria Triassi, Paolo Barone, Maria Teresa Pellecchia, Quitting smoking: An early non-motor feature of Parkinson's disease?, Parkinsonism & Related Disorders, 2015, 21, 3, 216

    CrossRef

  29. 29
    Kai Li, Heinz Reichmann, Tjalf Ziemssen, Recognition and treatment of autonomic disturbances in Parkinson’s disease, Expert Review of Neurotherapeutics, 2015, 15, 10, 1189

    CrossRef

  30. 30
    Jose L. López-Sendón Moreno, Araceli Alonso-Cánovas, Javier Buisán Catevilla, Nuria García Barragán, Iñigo Corral Corral, Alicia Felipe Mimbrera, María Consuelo Matute Lozano, Jaime Masjuan Vallejo, Juan Carlos Martínez-Castrillo, Substantia Nigra Echogenicity Predicts Response to Drug Withdrawal in Suspected Drug-Induced Parkinsonism, Movement Disorders Clinical Practice, 2015, 2, 4
  31. 31
    F. J. A. Meijer, A. van Rumund, B. A. C. M. Fasen, I. Titulaer, M. Aerts, R. Esselink, B. R. Bloem, M. M. Verbeek, B. Goraj, Susceptibility-Weighted Imaging Improves the Diagnostic Accuracy of 3T Brain MRI in the Work-Up of Parkinsonism, American Journal of Neuroradiology, 2015, 36, 3, 454

    CrossRef

  32. 32
    Charalampos Georgiopoulos, Anette Davidsson, Maria Engström, Elna-Marie Larsson, Helene Zachrisson, Nil Dizdar, The diagnostic value of dopamine transporter imaging and olfactory testing in patients with parkinsonian syndromes, Journal of Neurology, 2015, 262, 9, 2154

    CrossRef

  33. 33
    Stephen Mullin, Anthony Schapira, The genetics of Parkinson's disease, British Medical Bulletin, 2015, 114, 1, 39

    CrossRef

  34. 34
    S. Rossi, M. Ulivelli, The olfactory side of Parkinson disease: Relevance for clinical practice, Neurology, 2015, 85, 15, 1266

    CrossRef

  35. 35
    Magda Dąbrowska, Michał Schinwelski, Emilia J. Sitek, Anna Muraszko-Klaudel, Bogna Brockhuis, Zygmunt Jamrozik, Jarosław Sławek, The role of neuroimaging in the diagnosis of the atypical parkinsonian syndromes in clinical practice, Neurologia i Neurochirurgia Polska, 2015, 49, 6, 421

    CrossRef

  36. 36
    María T. Gómez-Caravaca, María T. Cáceres-Redondo, Ismael Huertas-Fernández, Laura Vargas-González, Fátima Carrillo, Manuel Carballo, Pablo Mir, The use of botulinum toxin in the treatment of sialorrhea in parkinsonian disorders, Neurological Sciences, 2015, 36, 2, 275

    CrossRef

  37. 37
    Ivanka Štenc Bradvica, Ivan Mihaljević, Silva Butković-Soldo, Dragutin Kadojić, Marina Titlić, Mario Bradvica, Kristina Kralik, Transcranial sonography and the pocket smell test in the differential diagnosis between parkinson’s disease and essential tremor, Neurological Sciences, 2015, 36, 8, 1403

    CrossRef

  38. 38
    Claudia Cacciari, Clelia Pellicano, Luca Cravello, Francesca Assogna, Fabrizio Piras, Patrizia Paravia, Tommaso Gili, Mariangela Iorio, Alessandro Stefani, Mariangela Pierantozzi, Carlo Caltagirone, Francesco E. Pontieri, Gianfranco Spalletta, Unraveling predictors affecting compliance to MRI in Parkinson's disease, Parkinsonism & Related Disorders, 2015, 21, 8, 964

    CrossRef

  39. 39
    Thomas Gasser, Usefulness of Genetic Testing in PD and PD Trials: A Balanced Review, Journal of Parkinson's Disease, 2015, 5, 2, 209

    CrossRef

  40. 40
    S. Lehericy, G. Bensimon, M. Vidailhet, Brain Mapping, 2015,

    CrossRef

  41. 41
    Susanne A. Schneider, Movement Disorders, 2015,

    CrossRef

  42. 42
    Luca Marsili, Rocco Agostino, Matteo Bologna, Daniele Belvisi, Adalgisa Palma, Giovanni Fabbrini, Alfredo Berardelli, Bradykinesia of posed smiling and voluntary movement of the lower face in Parkinson's disease, Parkinsonism & Related Disorders, 2014, 20, 4, 370

    CrossRef

  43. 43
    Anette Davidsson, Charalampos Georgiopoulos, Nil Dizdar, Göran Granerus, Helene Zachrisson, Comparison between visual assessment of dopaminergic degeneration pattern and semi-quantitative ratio calculations in patients with Parkinson’s disease and Atypical Parkinsonian syndromes using DaTSCAN® SPECT, Annals of Nuclear Medicine, 2014, 28, 9, 851

    CrossRef

  44. 44
    Mark D. Turner, Belinda Nedjai, Tara Hurst, Daniel J. Pennington, Cytokines and chemokines: At the crossroads of cell signalling and inflammatory disease, Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2014, 1843, 11, 2563

    CrossRef

  45. 45
    Marcello Moccia, Sabina Pappatà, Marina Picillo, Roberto Erro, Anna Rita Daniela Coda, Katia Longo, Carmine Vitale, Marianna Amboni, Arturo Brunetti, Giuseppe Capo, Marco Salvatore, Paolo Barone, Maria Teresa Pellecchia, Dopamine transporter availability in motor subtypes of de novo drug-naïve Parkinson’s disease, Journal of Neurology, 2014, 261, 11, 2112

    CrossRef

  46. 46
    Matthias Löhle, Carl-Johan Ramberg, Heinz Reichmann, Anthony H. V. Schapira, Early Versus Delayed Initiation of Pharmacotherapy in Parkinson’s Disease, Drugs, 2014, 74, 6, 645

    CrossRef

  47. 47
    Xiao-Ying Zhu, Tian-Hong Pan, William G. Ondo, Joohi Jimenez-Shahed, Yun-Cheng Wu, Effects of deep brain stimulation in relatively young-onset multiple system atrophy Parkinsonism, Journal of the Neurological Sciences, 2014, 342, 1-2, 42

    CrossRef

  48. 48
    D. Kupitz, I. Apostolova, C. Lange, G. Ulrich, H. Amthauer, W. Brenner, R. Buchert, Global scaling for semi-quantitative analysis in FP-CIT SPECT, Nuklearmedizin, 2014, 53, 6, 234

    CrossRef

  49. 49
    J. T. O'Brien, W. H. Oertel, I. G. McKeith, D. G. Grosset, Z. Walker, K. Tatsch, E. Tolosa, P. F. Sherwin, I. D. Grachev, Is ioflupane I123 injection diagnostically effective in patients with movement disorders and dementia? Pooled analysis of four clinical trials, BMJ Open, 2014, 4, 7, e005122

    CrossRef

  50. 50
    Pawel Piotr Dobrakowski, Agnieszka Kamila Machowska-Majchrzak, Beata Labuz-Roszak, Krzysztof Grzegorz Majchrzak, Ewa Kluczewska, MR-Guided Focused Ultrasound: A New Generation Treatment of Parkinsons Disease, Essential Tremor and Neuropathic Pain, Interventional Neuroradiology, 2014, 20, 0

    CrossRef

  51. 51
    D.V. Moretti, G. Binetti, O. Zanetti, G.B. Frisoni, Non-ergot dopamine agonist rotigotine as a promising therapeutic tool in atypical parkinsonism syndromes: A 24 months pilot observational open-label study, Neuropharmacology, 2014, 85, 284

    CrossRef

  52. 52
    Angelo Antonini, Roberta Biundo, Parkinson disease: Can dopamine transporter imaging define early PD?, Nature Reviews Neurology, 2014, 10, 8, 432

    CrossRef

  53. 53
    C. Comi, L. Magistrelli, G.D. Oggioni, M. Carecchio, T. Fleetwood, R. Cantello, F. Mancini, A. Antonini, Peripheral nervous system involvement in Parkinson's disease: Evidence and controversies, Parkinsonism & Related Disorders, 2014, 20, 12, 1329

    CrossRef

  54. 54
    R. Guignard, A. Schiazza, A. Ochin, J. Darcourt, Quantification de l’activité dopaminergique striatale en TEP à la 18F-DOPA : quels paramètres choisir en routine ?, Médecine Nucléaire, 2014, 38, 2, 91

    CrossRef

  55. 55
    R. Mahale, R. Yadav, P.K. Pal, Rapid eye movement sleep behaviour disorder in young- and older-onset Parkinson disease: a questionnaire-based study, Sleep Medicine, 2014, 15, 6, 642

    CrossRef

  56. 56
    A. H. V. Schapira, Recent advances in neurology 2013–2014, European Journal of Neurology, 2014, 21, 12
  57. 57
    Fabienne S. Sprenger, Klaus Seppi, Elisabeth Wolf, Werner Poewe, Relevance of EARLYSTIM in a tertiary movement disorders center, Movement Disorders, 2014, 29, 9
  58. 58
    Ping Liu, Xin Li, Fang-fei Li, Qiao-hong Ou-Yang, Hong-xia Zhang, Tao Feng, The predictive value of transcranial sonography in clinically diagnosed patients with early stage Parkinson's disease: Comparison with DAT PET scans, Neuroscience Letters, 2014, 582, 99

    CrossRef

  59. 59
    Kristina Laučkaitė, Daiva Rastenytė, Danguolė Šurkienė, Birutė Vaidelytė, Gabrielė Dambrauskaitė, Andrius Sakalauskas, Antanas Vaitkus, Rymantė Gleiznienė, Ultrasonographic (TCS) and clinical findings in overlapping phenotype of essential tremor and Parkinson’s disease (ET-PD), BMC Neurology, 2014, 14, 1, 54

    CrossRef

  60. 60
    Alice S. Chen-Plotkin, Unbiased Approaches to Biomarker Discovery in Neurodegenerative Diseases, Neuron, 2014, 84, 3, 594

    CrossRef

  61. 61
    L. Bonanni, G. Bontempo, I. Borrelli, S. Bifolchetti, M. P. Buongarzone, N. Carlesi, A. Carolei, F. Ciccocioppo, U. Colangelo, G. Colonna, M. Desiderio, S. Ferretti, L. Fiorelli, O. D’Alessio, A. D’Amico, M. C. D’Amico, R. De Lucia, L. Del Re, F. Di Blasio, R. Di Giacomo, A. Di Iorio, E. Di Santo, M. Di Giuseppe, N. Felice, P. Litterio, A. Gabriele, E. Mancino, L. Manzoli, V. Maruotti, S. Mearelli, G. Molino, D. Monaco, F. Nuccetelli, M. Onofrj, B. Perfetti, C. Sacchet, F. Sensi, S. Sensi, P. Sucapane, J. P. Taylor, A. Thomas, P. Viola, S. Viola, M. Zito, H. Zhuzhuni, Ascertainment bias in dementias: a secondary to tertiary centre analysis in Central Italy and conceptual review, Aging Clinical and Experimental Research, 2013, 25, 3, 265

    CrossRef

  62. You have free access to this content62
    Kazuyo Ikeda, Kazushi Deguchi, Kodai Kume, Masaki Kamada, Tetsuo Touge, Tsutomu Masaki, Assessment of sensory perception and processing using current perception threshold in Parkinson's disease, Neurology and Clinical Neuroscience, 2013, 1, 6
  63. 63
    Tomoaki Nakata, Akiyoshi Hashimoto, Hirohito Sugawara, Cardiac Metaiodobenzylguanidine Imaging and Heart Failure, Current Heart Failure Reports, 2013, 10, 4, 359

    CrossRef

  64. 64
    Georg Ebersbach, Caroline Moreau, Florin Gandor, Luc Defebvre, David Devos, Clinical syndromes: Parkinsonian gait, Movement Disorders, 2013, 28, 11
  65. 65
    C. Scherfler, R. Esterhammer, M. Nocker, P. Mahlknecht, H. Stockner, B. Warwitz, S. Spielberger, B. Pinter, E. Donnemiller, C. Decristoforo, I. Virgolini, M. Schocke, W. Poewe, K. Seppi, Correlation of dopaminergic terminal dysfunction and microstructural abnormalities of the basal ganglia and the olfactory tract in Parkinson's disease, Brain, 2013, 136, 10, 3028

    CrossRef

  66. 66
    W. Poewe, K. Seppi, Diagnosis of drug-induced parkinsonism: can transcranial sonography make the difference?, European Journal of Neurology, 2013, 20, 11
  67. 67
    Erratum, European Journal of Neurology, 2013, 20, 2
  68. 68
    Maria José Martí, Eduardo Tolosa, Parkinson disease: New guidelines for diagnosis of Parkinson disease, Nature Reviews Neurology, 2013, 9, 4, 190

    CrossRef

  69. 69
    David R. Williams, Irene Litvan, Parkinsonian Syndromes, CONTINUUM: Lifelong Learning in Neurology, 2013, 19, 1189

    CrossRef

  70. 70
    Anthony H.V. Schapira, Recent developments in biomarkers in Parkinson disease, Current Opinion in Neurology, 2013, 26, 4, 395

    CrossRef